Johnson & Johnson Adopts New By-Laws and Shareholder Approvals at 2024 Annual Meeting

Details

At the 2024 Annual Meeting of Shareholders, all 13 Director nominees were elected, the Say on Pay for executive compensation was approved, PricewaterhouseCoopers LLP was ratified as the independent auditor, and a shareholder proposal for gender-based compensation gaps was not approved.

Items reported

Exhibits (1)

About Johnson & Johnson

Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.